Tislelizumab/Zanubrutinib Regimen

Preferred Label : Tislelizumab/Zanubrutinib Regimen;

NCIt synonyms : Zanubrutinib/Tislelizumab; Tevimbra/Brukinsa; Tislelizumab Plus Zanubrutinib; Tislelizumab-jsgr/Zanubrutinib; Tislelizumab-Zanubrutinib; Tislelizumab/Zanubrutinib;

NCIt definition : A regimen consisting of tislelizumab and zanubrutinib that may be used in the treatment of chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).;

Détails

Origin ID

C213238;

chemotherapy_regimen_has_component
- Tislelizumab [NCIt concept]
- Zanubrutinib [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

All resources
or only the major
or use the search engine

recommendations
documents concerning education
documents for patients